Teva
Teva collaborates on skin disease treatment, releases targets
Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo
Teva seeks startups to help solve global pharmaceutical challenges
Placing the focus on the therapist
Does a common heart attack pill help everyone? Studies disagree
Ukrainian refugees offered free medical services in Israel
Many of them are not Jewish and are therefore ineligible for access to universal healthcare in Israel.
Rhode Island takes Teva to trial in multibillion-dollar opioid case
The multibillion-dollar trial will determine whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.
Teva, Texas strike opioid settlement worth $225 million
Teva Pharmaceutical Industries Ltd was facing claims that they fueled an opioid epidemic in Texas by improperly marketing addictive pain medications.
Drugmaker Teva fueled opioid addiction in New York, jury finds
New York and Nassau and Suffolk counties had accused the Israel-based drugmaker of engaging in misleading marketing practices that fueled opioid addiction in the state.
California judge rules for Israeli Teva in major opioid lawsuit
The lawsuit was originally filed in April, when several California counties accused drugmakers of fueling America's opioid crisis.
Israeli team says AI platform can predict which drugs are safe, effective
Quris, an artificial intelligence (AI) company operating in the pharmaceutical space, launched this week and announced a $9 million in seed funding.
Pfizer, AstraZeneca help launch 'computational science' lab in Israel
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
Moderna’s outgoing Israeli chief medical officer joins TEVA board
Dr. Tal Zaks will serve on the Teva board's science and technology committee.
Israel's Teva in talks to co-produce COVID-19 vaccines
Teva, the world's largest generics drugmaker, both approached and was approached by vaccine makers.
Meet the hospital staff's children joining the fight against coronavirus
The children have been developing their projects as part of the "Biotech - Next Generation" project.
